A short history of anti-rheumatic therapy. II. Aspirin;Piccola storia della terapia antireumatica. II. L'aspirina

Reumatismo

Volumn 62, Issue 2, 2010, Pages 148-156

  Pasero, G ^a   Marson, P ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aspirin; Drug industry; Haemostasis; History of rheumatology; Salicylates

Indexed keywords

ACETYLSALICYLIC ACID; HERBACEOUS AGENT; SALICYLIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ARTICLE; DRUG RESEARCH; FEVER; HISTORY OF MEDICINE; MALARIA; PAIN; PHARMACEUTICAL CARE; WILLOW; ART; BARK; FRANCE; GERMANY; HISTORY; HUMAN; ITALY; PHYTOTHERAPY; RHEUMATIC DISEASES; UNITED KINGDOM; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ENGLAND; FRANCE; GERMANY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; ITALY; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; RHEUMATIC DISEASES; SALICYLATES; SALIX; UNITED STATES;

EID: 77954876173     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Gross M, Greenberg LA. The salicylates. A critical bibliographic review. New Haven, Hillhouse Press, 1948.
2. Bywaters EGL. The history of salicylates. In: Salicylates. An international Symposium sponsored by the Empire Rheumatism Council (Dixon AStJ, Smith MJH, Martin BK, Wood PNH, eds), Boston, Little Brown, 1963.
3. Collier HOJ. Aspirin. Scientific American 1963; 209: 96-108.
4. Tainter ML, Ferris AJ. Aspirin in modern therapy. New York, Bayer Company Division of Sterling Drug, Inc., 1969.
5. Rodnan GP, Benedek TG. The early history of antirheumatic drugs. Arthritis Rheum 1970; 13: 145-65.
6. Schindler PE. Aspirin Therapy. New York, Walker & Co., 1978.
7. Rainsford KD. Aspirin and the salycilates. Woburn, Massachusetts, Butterworths Publishers Inc., 1984.
8. Léca AP. Histoire illustrée de la rhumatologie. Paris, Dacosta, 1987.
9. Weissmann G. Aspirin. Scientific American 1991; 264: 58-64.
10. Mann CC, Plummer ML. The aspirin wars: money, medicine and 100 years of rampant competition. New York, Alfred Koepf Inc., 1991.
11. Vane JR, Botting RM: Aspirin and other salicylates. London, Chapman & Hall Medical, 1992.
12. Mueller RL, Scheidt S. History of drugs for thrombotic disease: discovery, development, and directions for the future. Circulation 1994; 89: 432-49.
13. Zündorf U. Aspirin. 100 years. The future has just began. Leverkusen, Bayer, 1997.
14. Jack DB. One hundred years of aspirin. Lancet 1997; 350: 437-9.
15. Hedner T, Everts B. The early clinical history of salicylates in rheumatology and pain. Clin Rheumatol 1998; 17: 17-25.
16. Schiavon F, Ruffatti A, Todesco S. 100 anni di aspirina nelle malattie reumatiche. Reumatismo 1999; 51: 119-27.
17. Rinsema TJ. One hundred years of aspirin. Med Hist 1999; 43: 502-7.
18. Sneader W. The discovery of aspirin: a reappraisal. Br Med J 2000; 321: 1591-4.
19. Jones R. Nonsteroidal anti-inflammatory drugs prescribing: past, present, and future. Am J Med 2001; 110: S1-5.
20. Marson P, Pasero G. Il contributo italiano alla storia dei salicilati. Reumatismo 2006; 58: 66-75.
21. Butler RN. Thanks, Hippocrates, for the first miracle drug. Geriatrics 1998; 53: 15.
22. Riddle JM. Dioscorides on pharmacy and medicine. Austin, University of Texas Press, 1985.
23. Gatto Trocchi C. Magia e medicina popolare in Italia: rimedi empirici, decotti, pozioni e filtri magici per la cura della salute secondo le più diffuse ricette tradizionali. Roma, Newton Compton, 1983.
24. Haas H. History of antipyretic analgesic therapy. Am J Med 1983; 75 (5A): 1-3.
25. MacLagan TJ. The treatment of acute rheumatism by salicin. Lancet 1876; i: 342-3 e 383-4.
26. Hammerschmidt DE. The first commercial bottle of aspirin: March 6, 1899. J Lab Clin Med 1998; 132: 556.
27. Stone E. An account of the success of the bark of the willow in the cure of agues. Philos Trans R Soc Med London (Biol) 1763; 53: 195-200.
28. Lee MR. Plants against malaria. Part 1: Cinchona or the Peruvian bark. J R Physicians Edinb 2002; 32: 189-96.
29. Dodoens R. A Niewe Herball or Historie of Planes. London, Edm. Bollifant, 1595. Citato da (2).
30. Koelbing HM. Storia della Terapia Medica. Origgio, Ciba-Geigy Edizioni, 1989.
31. Leroux PJ. Découverte de la salicine. J Chim Méd 1830; 6: 341.
32. Rigatelli B. Sostituto indigeno del solfato di chinina. Biblioteca Italiana o sia Giornale di Letteratura, Scienze ed Arte 1824; 33: 267.
33. Fontana F. Salicina, principio medicamentoso del salice bianco (Salix alba) o base vegetale salificabile. Giornale di farmacia-chimica e scienze accessorie 1824; 1: 644-8.
34. Marson P, Pasero G. A mistake in the history of aspirin. Clin Exp Rheumatol 2005; 23: 913.
35. Piria R. Recherches sur la salicine et les produits qui en dérivent. Ann Chim Phys 1838; 69: 218-325.
36. Zito F. Raffaele Piria e la sua opera. Bari, Laterza, 1917.
37. Karl T, Guenther A, Turnipseed A, Patton EG, Jardine K. Chemical sensing of plant stress at the ecosystem scale. Biogeosciences 2008; 5: 1287-94.
38. Kolbe H. Über die Synthese der Salicylsäure. Liebigs Ann 1860; 113: 125-7.
39. Kolbe H. Über eine neue Darstellungsmethode und einige bemerkemswerte Eigenschaften der Salicylsäure. J Prakt Chem 1874; 10: 89-112.
40. Sneader W. Drug discovery. Chichester, John Wiley & Sons, 1985
41. von Gilm H. Acetylderivate der Phloretin und Salicylsäure. Liebigs Ann 1859; 112: 180-2.
42. Gerhardt CF. Untersuchungen über die wasserfrein organischen Säuren. Ann Chim Pharm 1853; 87: 149-79. Citato da (8).
43. Buchanan WW, Kean WF. The treatment of acute rheumatism by salicin, by T.J. MacLagan The Lancet, 1876. J Rheumatol 2002; 29: 1321-3.
44. Stricker F. Aus der Traubschen Klinik. Über die Resultate der Behandlung des Polyarthritis rheumatica mit Salicylsäure. Berl Klein Wschr 1876; 13: 1-2/8/13 e 15. Citato da (15).
45. Reiss L. Nachtrag zur Anwendung der Salicylsäure bei dem akuten Gelenkrheumatismus. Berl Klein Wschr 1876; 13: 86-9. Citato da (5).
46. Sée G. Études sur l'acide salicylique et les salicylates; traitement du rhumatisme aigu et chronique, de la goutte et des diverses affections du système nerveux sensitif par les salicylates. Bull Acad Méd Paris 1877, 6, 689-897. Citato da (8).
47. McTavish JR. What did Bayer do before aspirin? Pharm Hist (Lond) 1999; 41: 3-15.
48. Eichengrün A. 50 Jahre Aspirin. Pharmazie 1949; 4: 582-4.
49. Hamilton GR, Baskett TF. In the arms of Morpheus: the development of morphine for postoperative pain relief. Can J Anaesth 2000; 47: 367-74.
50. Dreser H. Pharmacologisches über Aspirin (Acetylsalicylsäure). Pflugers Arch 1899; 76: 306-18.
51. Witthauer K. Aspirin, ein neues Salicylpräparat. Die Heilkunde 1899; 3: 396-8.
52. Wohlgemut J. Über Aspirin (Acetylsalicylsäure). Therap Mschr 1899; 3: 276-8.
53. Floeckinger FC. An experimental study of aspirin, a new salicylic acid preparation. Med News 1899; 75: 641-72.
54. Burnet J. The therapeutics of aspirin and mesotan. Lancet 1905; i: 1193-6.
55. Doutre LP, Perissat J, Hirigoyen P, Beaulieu JC. Utilization of E.B. 49G (lysine acetylsalicylate) in intramuscolar administration in post-operative analgesia. Bord Med 1970; 3: 3081-2.
56. Bertagnini C. Sulle alterazioni che alcuni acidi subiscono nell'organismo animale. Il Nuovo Cimento 1855; 1: 363-72.
57. Leist ER, Ranvell JB. Products containing aspirin. New Engl J Med 1974; 291: 710-2.
58. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 1971; 231: 232-5.
59. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-6.
60. Wilhelmi G. Über einem neuen Präparatus der Pyrazolreihe. Schweiz Med Wschr 1949; 79: 577.
61. Hench PS, Kendall EC, Slocumb CF, Polley PF. The effects of a hormone of the adrenal cortex (17-hydroxy 11-dehydrocorticosterone, compound E) and of pituitary adrenocorticotrophic hormone in rheumatoid arthritis; a preliminary report. Proc Staff Meet Mayo Clin 1949; 24: 181-7.
62. Anonimo. Alka-Seltzer. Med Lett Drugs 1973; 15: 36.
63. Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: a summary review to 2007. Recent Reults Cancer Res 2009; 181: 231-51.
64. Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G. Aspirin, salicylates, and cancer. Lancet 2009; 373: 1301-9.
65. Balette E. De l'action du salicylate de soude sur l'uterus. Paris, Ollier-Henry, 1883.
66. Binz C. Über Wirkung der Salicylsäure auf die Gessärmutter. Berl Klin Wschr 1893; 30: 85-7.
67. Bickel MH. Carl Binz (1832-1913): an early pioneer of pharmacology and chemotherapy. Pharm Hist (Lond), 1996; 38: 134-9.
68. Jeffreys D. Aspirin. The Remarkable Story of a Wonder Drug. New York, Bloomsbury Publishing, 2004.
69. Link KP, Overman RS, Sullivan WR, Nuebner CF, Scheel LD. Studies on hemorrhagic sweet clover disease. J Biol Chem 1943; 147: 463-74.
70. Kresge N, Simoni RD, Hill RL. Hemorrhagic sweet clover disease, dicumarol, and warfarin: the work of Karl Paul Link. J Biol Chem. 2005; 280: e5.
71. Gibson PC. Salicylic acid for coronary thrombosis? Lancet 1948; i: 965.
72. Gibson PC. Aspirin in the treatment of vascular diseases. Lancet 1949; ii: 1172-4.
73. Beaumont JL, Willie A. Influence sur l'hémostase, de l'hypertension arterielle, des antivitamines K, de l'héparine et de l'acide acétylsalicylique. Sang 1955; 26: 880-91.
74. Bounameaux Y, Van Cauwenberge H. Action de la cortison, de l'ACTH e du salicylate de soude sur les thrombocytes et la coagulation sanguine. Sang 1954; 25: 889-99.
75. Craven LL. Acetylsalicylic acid, possible preventive of coronary thrombosis. Ann West Med Surg 1950; 4:95-9.
76. Craven LL. Coronary thrombosis can be prevented. J Insur Med 1950; 5: 47-9.
77. Craven LL. Experience with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley J Med 1953; 75: 38-44.
78. Lovell R. Lord Moran's prescriptions for Churchill. Br Med J 1995; 310: 1537-8.
79. Weiss HJ. The discovery of the antiplatelet effect of aspirin: a personal reminiscence. J Thromb Haemost 2003; 1: 1869-75.
80. Weiss HJ, Aledort LM. Impaired platelet-connective tissue reaction in man after aspirin ingestion. Lancet 1967; ii: 495-7.
81. Born GV. Platelets: some historical background. Agents Actions Suppl 1987; 21: 11-21.
82. Born M. Autobiografia di un fisico. 2a edizione, trad. P.Camiz, Roma, Ed. Riuniti, 2005.
83. The Coronary Drug Project Research Group. Aspirin and coronary heart disease. J Chron Dis 1976; 29: 625-42.
84. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-9.
85. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003; 163: 2006-10.
86. Vane JR. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J Physiol Pharmacol 2000; 51: 573-86.